Cargando…

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk

BACKGROUND: GlycA is a novel spectroscopic marker of systemic inflammation with low intra-individual variability and other attributes favoring its clinical use in patients with chronic inflammatory and autoimmune diseases. GlycA is unique in its composite nature, reflecting both increased glycan com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connelly, Margery A., Otvos, James D., Shalaurova, Irina, Playford, Martin P., Mehta, Nehal N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658936/ https://www.ncbi.nlm.nih.gov/pubmed/29078787 http://dx.doi.org/10.1186/s12967-017-1321-6

Ejemplares similares

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children
por: Connelly, Margery A., et al.
Publicado: (2016)

GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2015)

Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
por: Ormseth, Michelle J., et al.
Publicado: (2015)

A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
por: Bartlett, David B., et al.
Publicado: (2016)

GlycA is not a useful biomarker of inflammation in sickle cell disease
por: Weisman, Julie K., et al.
Publicado: (2018)

GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()
por: Mehta, Nehal N., et al.
Publicado: (2020)

GlycA: Evaluation of a New Biomarker of Acute Pancreatitis
por: Shah, Ishani, et al.
Publicado: (2023)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022)

Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes
por: Bartlett, David B., et al.
Publicado: (2017)

GlycA, a Biomarker of Low-Grade Inflammation, Is Increased in Male Night Shift Workers
por: Bizzarri, Daniele, et al.
Publicado: (2022)

Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates
por: Fung, Erik, et al.
Publicado: (2023)

The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Jang, Sunyoung, et al.
Publicado: (2021)

Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
por: Riggs, Kayla A., et al.
Publicado: (2019)

Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife
por: Cohen-Manheim, Irit, et al.
Publicado: (2015)

GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis
por: Gruppen, E. G., et al.
Publicado: (2019)

GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2020)

Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
por: Assone, Tatiane, et al.
Publicado: (2022)

GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD
por: Dierckx, Tim, et al.
Publicado: (2019)

The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
por: Puig-Jové, Carlos, et al.
Publicado: (2022)

Elevated serum alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality
por: Ritchie, Scott C., et al.
Publicado: (2019)

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
por: Dierckx, Tim, et al.
Publicado: (2020)

GlycA, a marker of protein glycosylation, is related to albuminuria and estimated glomerular filtration rate: the ELSA-Brasil study
por: Titan, Silvia M., et al.
Publicado: (2017)

GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile
por: Mokkala, Kati, et al.
Publicado: (2020)

A Dietitian-Led Vegan Program May Improve GlycA, and Other Novel and Traditional Cardiometabolic Risk Factors in Patients With Dyslipidemia: A Pilot Study
por: Chiu, Tina H. T., et al.
Publicado: (2022)

Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
por: Kianoush, Sina, et al.
Publicado: (2017)

High-throughput nuclear magnetic resonance measurement of citrate in serum and plasma in the clinical laboratory
por: Garcia, Erwin, et al.
Publicado: (2021)

Ketone Bodies Are Mildly Elevated in Subjects with Type 2 Diabetes Mellitus and Are Inversely Associated with Insulin Resistance as Measured by the Lipoprotein Insulin Resistance Index
por: Garcia, Erwin, et al.
Publicado: (2020)

Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
Publicado: (2017)

A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort
por: Flores-Guerrero, Jose L., et al.
Publicado: (2020)

A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2018)

Effects of Amount, Intensity, and Mode of Exercise Training on Insulin Resistance and Type 2 Diabetes Risk in the STRRIDE Randomized Trials
por: Ross, Leanna M., et al.
Publicado: (2021)

High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study
por: Garcia, Erwin, et al.
Publicado: (2019)

Association of beta‐hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2020)

ProGlycProt: a repository of experimentally characterized prokaryotic glycoproteins
por: Bhat, Aadil H., et al.
Publicado: (2012)

Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay
por: Bedi, Shimpi, et al.
Publicado: (2020)

The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B
por: Garcia, Erwin, et al.
Publicado: (2020)

Nuclear Magnetic Resonance-Measured Ionized Magnesium Is Inversely Associated with Type 2 Diabetes in the Insulin Resistance Atherosclerosis Study
por: Garcia, Erwin, et al.
Publicado: (2022)

Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study
por: Schutten, Joëlle C., et al.
Publicado: (2019)

O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease
por: Zhou, Yicheng, et al.
Publicado: (2022)

Calorie restriction improves lipid-related emerging cardiometabolic risk factors in healthy adults without obesity: Distinct influences of BMI and sex from CALERIE™ a multicentre, phase 2, randomised controlled trial
por: Huffman, Kim M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_16n5o8qfuug9vl7sgtu4g82a6m